Global Cell Therapy Technology Market

Cell Therapy Technology Comprehensive Study by Type (Consumables, Equipment {Cell Processing Equipment, Single-Use Equipment and Other}, Systems and Software), Process (Cell Processing, Cell Preservation, Distribution and Handling, Process Monitoring and Quality Control), Cell (Human Cells {Stem Cells and Differential Cells}, Animal Cells) Players and Region - Global Market Outlook to 2026

Cell Therapy Technology Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Cell Therapy Technology Market?

Cell therapy is a therapy in which cellular material is injected, grafted or implanted into a patient. It is a technology that relies on replacing diseased or dysfunctional cells with healthy, functioning ones. The form of cell therapy are whole blood transfusions, packed red cell transfusions, platelet transfusions, bone marrow transplants and organ transplants. It is applicable to some types of cancer, neurological diseases such as Parkinson disease and amyotrophic lateral sclerosis, spinal cord injuries and diabetes.

The market study is being classified by Type (Consumables, Equipment {Cell Processing Equipment, Single-Use Equipment and Other} and Systems and Software) and major geographies with country level break-up.

Beckman Coulter (United States), Vericel Corporation (United States), Thermo Fisher Scientific (United States), Becton, Dickinson and Company (United States), GE Healthcare (United States), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada) and Terumo BCT (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Kolon TissueGene, Inc. (United States), JCR Pharmaceuticals Co., Ltd. (Japan), Mesoblast Ltd (Australia), Osiris Therapeutics, Inc. (United States) and NuVasive, Inc. (United States).

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Cell Therapy Technology market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Cell Therapy Technology market by Type, Application and Region.

On the basis of geography, the market of Cell Therapy Technology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Rising Number of People Affecting Cancer and Chronic Diseases
  • Declining Prices of the Stem Cell Therapies

Market Trend
  • Technological Improvement and Advancements

Restraints
  • High Cost of Cell-Based Research and Low Success Rate

Opportunities
  • Government Investments in Cell-Based Research
  • Increasing Adoption of Regenerative Medicine
  • Growing Aging Population Worldwide

Challenges
  • Stringent Regulatory Policies


Market Leaders and some development strategies
On 1st May 2019, Thermo Fisher Scientific Inc., the world leader in serving science, completed the acquisition of Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies.
On 16th May 2019, GE Healthcare launched automation software for cell therapy. It has been designed to fit specific requirements to incorporate the platform into existing software and hardware framework. Chronicle automation software is a GMP compliant fit for purpose digital solution designed to optimize complex cell therapy process development and manufacturing


Key Target Audience
Cell Therapy Technology Providers, Research Institutes, Emerging Companies, Government Body & Associations and End-user

Report Objectives / Segmentation Covered

By Type
  • Consumables
  • Equipment {Cell Processing Equipment, Single-Use Equipment and Other}
  • Systems and Software
By Process
  • Cell Processing
  • Cell Preservation, Distribution and Handling
  • Process Monitoring and Quality Control

By Cell
  • Human Cells {Stem Cells and Differential Cells}
  • Animal Cells

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Number of People Affecting Cancer and Chronic Diseases
      • 3.2.2. Declining Prices of the Stem Cell Therapies
    • 3.3. Market Challenges
      • 3.3.1. Stringent Regulatory Policies
    • 3.4. Market Trends
      • 3.4.1. Technological Improvement and Advancements
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Cell Therapy Technology, by Type, Process, Cell and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Cell Therapy Technology (Value)
      • 5.2.1. Global Cell Therapy Technology by: Type (Value)
        • 5.2.1.1. Consumables
        • 5.2.1.2. Equipment {Cell Processing Equipment, Single-Use Equipment and Other}
        • 5.2.1.3. Systems and Software
      • 5.2.2. Global Cell Therapy Technology by: Process (Value)
        • 5.2.2.1. Cell Processing
        • 5.2.2.2. Cell Preservation, Distribution and Handling
        • 5.2.2.3. Process Monitoring and Quality Control
      • 5.2.3. Global Cell Therapy Technology by: Cell (Value)
        • 5.2.3.1. Human Cells {Stem Cells and Differential Cells}
        • 5.2.3.2. Animal Cells
      • 5.2.4. Global Cell Therapy Technology Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Cell Therapy Technology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Beckman Coulter (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Vericel Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Thermo Fisher Scientific (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Becton, Dickinson and Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. GE Healthcare (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Lonza (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Merck KGaA (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Miltenyi Biotec (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. STEMCELL Technologies, Inc. (Canada)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Terumo BCT (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Cell Therapy Technology Sale, by Type, Process, Cell and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Cell Therapy Technology (Value)
      • 7.2.1. Global Cell Therapy Technology by: Type (Value)
        • 7.2.1.1. Consumables
        • 7.2.1.2. Equipment {Cell Processing Equipment, Single-Use Equipment and Other}
        • 7.2.1.3. Systems and Software
      • 7.2.2. Global Cell Therapy Technology by: Process (Value)
        • 7.2.2.1. Cell Processing
        • 7.2.2.2. Cell Preservation, Distribution and Handling
        • 7.2.2.3. Process Monitoring and Quality Control
      • 7.2.3. Global Cell Therapy Technology by: Cell (Value)
        • 7.2.3.1. Human Cells {Stem Cells and Differential Cells}
        • 7.2.3.2. Animal Cells
      • 7.2.4. Global Cell Therapy Technology Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cell Therapy Technology: by Type(USD Million)
  • Table 2. Cell Therapy Technology Consumables , by Region USD Million (2015-2020)
  • Table 3. Cell Therapy Technology Equipment {Cell Processing Equipment, Single-Use Equipment and Other} , by Region USD Million (2015-2020)
  • Table 4. Cell Therapy Technology Systems and Software , by Region USD Million (2015-2020)
  • Table 5. Cell Therapy Technology: by Process(USD Million)
  • Table 6. Cell Therapy Technology Cell Processing , by Region USD Million (2015-2020)
  • Table 7. Cell Therapy Technology Cell Preservation, Distribution and Handling , by Region USD Million (2015-2020)
  • Table 8. Cell Therapy Technology Process Monitoring and Quality Control , by Region USD Million (2015-2020)
  • Table 9. Cell Therapy Technology: by Cell(USD Million)
  • Table 10. Cell Therapy Technology Human Cells {Stem Cells and Differential Cells} , by Region USD Million (2015-2020)
  • Table 11. Cell Therapy Technology Animal Cells , by Region USD Million (2015-2020)
  • Table 12. South America Cell Therapy Technology, by Country USD Million (2015-2020)
  • Table 13. South America Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 14. South America Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 15. South America Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 16. Brazil Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 17. Brazil Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 18. Brazil Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 19. Argentina Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 20. Argentina Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 21. Argentina Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 22. Rest of South America Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 23. Rest of South America Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 24. Rest of South America Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 25. Asia Pacific Cell Therapy Technology, by Country USD Million (2015-2020)
  • Table 26. Asia Pacific Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 27. Asia Pacific Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 28. Asia Pacific Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 29. China Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 30. China Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 31. China Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 32. Japan Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 33. Japan Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 34. Japan Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 35. India Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 36. India Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 37. India Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 38. South Korea Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 39. South Korea Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 40. South Korea Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 41. Taiwan Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 42. Taiwan Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 43. Taiwan Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 44. Australia Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 45. Australia Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 46. Australia Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 47. Rest of Asia-Pacific Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 50. Europe Cell Therapy Technology, by Country USD Million (2015-2020)
  • Table 51. Europe Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 52. Europe Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 53. Europe Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 54. Germany Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 55. Germany Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 56. Germany Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 57. France Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 58. France Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 59. France Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 60. Italy Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 61. Italy Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 62. Italy Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 63. United Kingdom Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 64. United Kingdom Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 65. United Kingdom Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 66. Netherlands Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 67. Netherlands Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 68. Netherlands Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 69. Rest of Europe Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 70. Rest of Europe Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 71. Rest of Europe Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 72. MEA Cell Therapy Technology, by Country USD Million (2015-2020)
  • Table 73. MEA Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 74. MEA Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 75. MEA Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 76. Middle East Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 77. Middle East Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 78. Middle East Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 79. Africa Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 80. Africa Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 81. Africa Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 82. North America Cell Therapy Technology, by Country USD Million (2015-2020)
  • Table 83. North America Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 84. North America Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 85. North America Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 86. United States Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 87. United States Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 88. United States Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 89. Canada Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 90. Canada Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 91. Canada Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 92. Mexico Cell Therapy Technology, by Type USD Million (2015-2020)
  • Table 93. Mexico Cell Therapy Technology, by Process USD Million (2015-2020)
  • Table 94. Mexico Cell Therapy Technology, by Cell USD Million (2015-2020)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Cell Therapy Technology: by Type(USD Million)
  • Table 106. Cell Therapy Technology Consumables , by Region USD Million (2021-2026)
  • Table 107. Cell Therapy Technology Equipment {Cell Processing Equipment, Single-Use Equipment and Other} , by Region USD Million (2021-2026)
  • Table 108. Cell Therapy Technology Systems and Software , by Region USD Million (2021-2026)
  • Table 109. Cell Therapy Technology: by Process(USD Million)
  • Table 110. Cell Therapy Technology Cell Processing , by Region USD Million (2021-2026)
  • Table 111. Cell Therapy Technology Cell Preservation, Distribution and Handling , by Region USD Million (2021-2026)
  • Table 112. Cell Therapy Technology Process Monitoring and Quality Control , by Region USD Million (2021-2026)
  • Table 113. Cell Therapy Technology: by Cell(USD Million)
  • Table 114. Cell Therapy Technology Human Cells {Stem Cells and Differential Cells} , by Region USD Million (2021-2026)
  • Table 115. Cell Therapy Technology Animal Cells , by Region USD Million (2021-2026)
  • Table 116. South America Cell Therapy Technology, by Country USD Million (2021-2026)
  • Table 117. South America Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 118. South America Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 119. South America Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 120. Brazil Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 121. Brazil Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 122. Brazil Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 123. Argentina Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 124. Argentina Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 125. Argentina Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 126. Rest of South America Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 127. Rest of South America Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 128. Rest of South America Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 129. Asia Pacific Cell Therapy Technology, by Country USD Million (2021-2026)
  • Table 130. Asia Pacific Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 131. Asia Pacific Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 132. Asia Pacific Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 133. China Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 134. China Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 135. China Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 136. Japan Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 137. Japan Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 138. Japan Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 139. India Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 140. India Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 141. India Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 142. South Korea Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 143. South Korea Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 144. South Korea Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 145. Taiwan Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 146. Taiwan Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 147. Taiwan Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 148. Australia Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 149. Australia Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 150. Australia Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 151. Rest of Asia-Pacific Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 152. Rest of Asia-Pacific Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 153. Rest of Asia-Pacific Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 154. Europe Cell Therapy Technology, by Country USD Million (2021-2026)
  • Table 155. Europe Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 156. Europe Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 157. Europe Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 158. Germany Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 159. Germany Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 160. Germany Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 161. France Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 162. France Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 163. France Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 164. Italy Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 165. Italy Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 166. Italy Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 167. United Kingdom Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 168. United Kingdom Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 169. United Kingdom Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 170. Netherlands Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 171. Netherlands Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 172. Netherlands Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 173. Rest of Europe Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 174. Rest of Europe Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 175. Rest of Europe Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 176. MEA Cell Therapy Technology, by Country USD Million (2021-2026)
  • Table 177. MEA Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 178. MEA Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 179. MEA Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 180. Middle East Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 181. Middle East Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 182. Middle East Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 183. Africa Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 184. Africa Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 185. Africa Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 186. North America Cell Therapy Technology, by Country USD Million (2021-2026)
  • Table 187. North America Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 188. North America Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 189. North America Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 190. United States Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 191. United States Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 192. United States Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 193. Canada Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 194. Canada Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 195. Canada Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 196. Mexico Cell Therapy Technology, by Type USD Million (2021-2026)
  • Table 197. Mexico Cell Therapy Technology, by Process USD Million (2021-2026)
  • Table 198. Mexico Cell Therapy Technology, by Cell USD Million (2021-2026)
  • Table 199. Research Programs/Design for This Report
  • Table 200. Key Data Information from Secondary Sources
  • Table 201. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cell Therapy Technology: by Type USD Million (2015-2020)
  • Figure 5. Global Cell Therapy Technology: by Process USD Million (2015-2020)
  • Figure 6. Global Cell Therapy Technology: by Cell USD Million (2015-2020)
  • Figure 7. South America Cell Therapy Technology Share (%), by Country
  • Figure 8. Asia Pacific Cell Therapy Technology Share (%), by Country
  • Figure 9. Europe Cell Therapy Technology Share (%), by Country
  • Figure 10. MEA Cell Therapy Technology Share (%), by Country
  • Figure 11. North America Cell Therapy Technology Share (%), by Country
  • Figure 12. Global Cell Therapy Technology share by Players 2020 (%)
  • Figure 13. Global Cell Therapy Technology share by Players (Top 3) 2020(%)
  • Figure 14. Global Cell Therapy Technology share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Beckman Coulter (United States) Revenue, Net Income and Gross profit
  • Figure 17. Beckman Coulter (United States) Revenue: by Geography 2020
  • Figure 18. Vericel Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 19. Vericel Corporation (United States) Revenue: by Geography 2020
  • Figure 20. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 21. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 22. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 23. Becton, Dickinson and Company (United States) Revenue: by Geography 2020
  • Figure 24. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 25. GE Healthcare (United States) Revenue: by Geography 2020
  • Figure 26. Lonza (Switzerland) Revenue, Net Income and Gross profit
  • Figure 27. Lonza (Switzerland) Revenue: by Geography 2020
  • Figure 28. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Merck KGaA (Germany) Revenue: by Geography 2020
  • Figure 30. Miltenyi Biotec (Germany) Revenue, Net Income and Gross profit
  • Figure 31. Miltenyi Biotec (Germany) Revenue: by Geography 2020
  • Figure 32. STEMCELL Technologies, Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 33. STEMCELL Technologies, Inc. (Canada) Revenue: by Geography 2020
  • Figure 34. Terumo BCT (United States) Revenue, Net Income and Gross profit
  • Figure 35. Terumo BCT (United States) Revenue: by Geography 2020
  • Figure 36. Global Cell Therapy Technology: by Type USD Million (2021-2026)
  • Figure 37. Global Cell Therapy Technology: by Process USD Million (2021-2026)
  • Figure 38. Global Cell Therapy Technology: by Cell USD Million (2021-2026)
  • Figure 39. South America Cell Therapy Technology Share (%), by Country
  • Figure 40. Asia Pacific Cell Therapy Technology Share (%), by Country
  • Figure 41. Europe Cell Therapy Technology Share (%), by Country
  • Figure 42. MEA Cell Therapy Technology Share (%), by Country
  • Figure 43. North America Cell Therapy Technology Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Beckman Coulter (United States)
  • Vericel Corporation (United States)
  • Thermo Fisher Scientific (United States)
  • Becton, Dickinson and Company (United States)
  • GE Healthcare (United States)
  • Lonza (Switzerland)
  • Merck KGaA (Germany)
  • Miltenyi Biotec (Germany)
  • STEMCELL Technologies, Inc. (Canada)
  • Terumo BCT (United States)
Additional players considered in the study are as follows:
Kolon TissueGene, Inc. (United States) , JCR Pharmaceuticals Co., Ltd. (Japan) , Mesoblast Ltd (Australia) , Osiris Therapeutics, Inc. (United States) , NuVasive, Inc. (United States)
Select User Access Type

Key Highlights of Report


Sep 2021 287 Pages 62 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Cell Therapy Technology Market Quantitative research analysis
Global Cell Therapy Technology Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Rising Number of People Affecting Cancer and Chronic Diseases " is seen as one of major growth factors of Cell Therapy Technology Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
United States will lead Cell Therapy Technology Market in coming years.

Know More About Global Cell Therapy Technology Market Report?

Have a Query? Click Here

Other Related Reports

Micro Algae Paste for Aquaculture Comprehensive Study by Contents (Omega-3 Fatty Acid, Omega-6 Fatty Acid), Hatcheries Applications (Marine Fish, Shrimp, Milkfish, Others (Shellfish, Tilapia)), Paste...
$ 3650
Cultured Meat Comprehensive Study by Type (Poultry, Pork, Beef, Duck), Application (Nuggets, Burgers, Meatballs, Sausages, Hot dogs, Others (include pet food and foie gras)), Distribution Channel (On...
$ 3500
Glycan Analysis Comprehensive Study by Analysis (Mass Spectrometry (MS), High-Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE), Isoelectric Focusing (IEF) Polyacrylamide Gel (...
$ 3450
Biomedical Nanotechnology Comprehensive Study by Application (Diagnostics, Sensing, Drugs, Prostheses and Implants, Others), Product (Treatment, Nanomedicine (Nanosensors), Agricultural Technology, G...
$ 3450
Biofermin Comprehensive Study by Type (Tablets, Powdery, Other), Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Players and Region - Global Market Outlook to 2026
$ 3500
Gallnuts Acid Comprehensive Study by Type (Industrial Grade, Pharmaceutical Grade, Food Grade), Application (Antioxidants, Biological Activity, Medical applications, Other), Extract (Gallnuts, Sumac,...
$ 3350